Forbion European Acquisition Corp.

Merged

CIK: 1874495•Ticker: FRBN

Successfully merged with enGene • Now trading as

SPAC Overview

$100M

IPO Size

Completed

Current Status

2021

IPO Year

Timeline Progress

Investment Focus

Life Sciences

SPAC Team

Sponsors

Forbion Growth Sponsor FEAC I Forbion European Sponsor LLP

Leadership

Chief Executive Officer and Director(1)

Chief Financial Officer and Director(1)

Sander Slootweg

Director (nominee)

Director (nominee)

Philip Astley-Sparke

Director (nominee)(2)

Hilde Steineger

Director (nominee)(2)

Director (nominee)(2)

Underwriters

UBS Securities Kempen & Co. USA

Key Information

IPO Date

December 11, 2021

Completion Date

October 24, 2023

Merger Target

enGene

SPAC Ticker

FRBNU

External Resources

View Detailed Analysis